Research
New studies and research findings from medicine, explained clearly.
-
Klotho as an mRNA Therapy: First Trial of the “Longevity Protein” in Healthy Adults
The start-up Klothea Bio is testing an mRNA therapy intended to raise blood levels of Klotho. The small trial is taking place…
-
Rejuvenation in the Brain: Reprogramming Gene Therapy for Alzheimer’s Moves Closer
The start-up YouthBio Therapeutics wants to rejuvenate nerve cells epigenetically using Yamanaka factors. The FDA has judged the preclinical data sufficient for…
-
Dogs Lead the Way: The First Longevity Drug and Gene Therapies for Older Dogs
The FDA has completed another review step for LOY-002, a tablet intended to extend the healthy life of older dogs. In parallel,…
-
101 Million Dollars for Ten Healthy Years: XPRIZE Healthspan Enters the Clinical Phase
20 teams have reached the final of the largest XPRIZE competition. By 2029, they must show in clinical trials that their therapies…
-
144 Million Dollars for More Healthy Years: US Agency ARPA-H Launches PROSPR Ageing Programme
With up to 144 million dollars, the US health research agency ARPA-H is funding seven teams to develop biomarkers, medicines and new…
-
Which Organ Ages Faster? AI Reads Biological Age from Tissue Samples
Researchers in Vienna have used artificial intelligence to develop “tissue clocks” for 40 tissue types. They show that the lungs, kidneys and…
-
Removing “Zombie Cells”: Where Senolytics Research Stands in 2026
Senolytics are intended to selectively eliminate aged, pro-inflammatory cells. After promising animal experiments, results in humans have so far been mixed –…
-
Plasma Exchange Against Ageing? What the First Placebo-Controlled Trial Shows
At the Buck Institute, regular exchange of blood plasma in healthy people over 50 reduced biological age by up to 2.6 years…
-
Lowering Cholesterol with Gene Scissors: CRISPR Therapy CTX310 Still Works After One Year
A single infusion that switches off the ANGPTL3 gene in the liver permanently lowers LDL cholesterol and triglycerides. The one-year data from…
-
Casgevy: First CRISPR Therapy Now Also Approved for Children Aged Two and Over
The US Food and Drug Administration has extended the gene therapy Casgevy for sickle cell disease and beta thalassaemia to children aged…
